Renaissance Capital logo

ODT News

US IPO Week Ahead: 2018 IPO market kicks off with a quiet week

QTRX

There are no deals set to price in the first week of the new year; however, filing activity will continue from companies targeting 1Q18 IPOs. The IPO market rounded out 2017 at an even 160 IPOs, raising $35.5 billion in total proceeds, nearly double that of 2016...read more

US IPO Weekly Recap: Year's largest biotech headlines 6-IPO week

DNLI

Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more

Odonate Therapeutics prices IPO at $24, the low end of the range

Odonate Therapeutics logo

Odonate Therapeutics, which is developing an oral chemotherapy drug for breast cancer, raised $150 million by offering 6.3 million shares at $24, the low end of the range of $24 to $27. Odonate Therapeutics plans to list on the Nasdaq under the symbol ODT....read more

US IPO Week Ahead: Two big biotechs lead 6-IPO week

CURO

The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, ...read more